Boai NKY Medical Holdings Ltd. (SHE:300109)
China · Delayed Price · Currency is CNY 18.93
+0.27 (1.45%)
Apr 29, 2026, 3:04 PM CST
Boai NKY Medical Holdings Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,178 | 1,588 | 1,562 | 1,449 | 1,196 |
Other Revenue | - | 18.81 | 20.93 | 36.66 | 23.94 |
| 1,178 | 1,606 | 1,583 | 1,486 | 1,220 | |
Revenue Growth (YoY) | -26.66% | 1.45% | 6.58% | 21.75% | 24.70% |
Cost of Revenue | 638.97 | 856.29 | 689.03 | 795.1 | 732.99 |
Gross Profit | 539.12 | 750.03 | 894.39 | 690.59 | 487.28 |
Selling, General & Admin | 164.84 | 206.41 | 235.76 | 188.03 | 253.44 |
Research & Development | 73.5 | 71.51 | 63.71 | 65.73 | 75.53 |
Other Operating Expenses | 3.47 | 12.69 | 13.97 | 9.6 | 11.45 |
Operating Expenses | 241.81 | 317.26 | 323.04 | 309.18 | 352.11 |
Operating Income | 297.31 | 432.78 | 571.35 | 381.42 | 135.17 |
Interest Expense | - | -7.04 | -2.07 | -2.62 | -37.73 |
Interest & Investment Income | 0.47 | 36.97 | 13.59 | 23.53 | 235.9 |
Currency Exchange Gain (Loss) | - | 5.04 | -1.4 | 23.11 | -0.8 |
Other Non Operating Income (Expenses) | -25.63 | -7.51 | -3.37 | -6.45 | -7.41 |
EBT Excluding Unusual Items | 272.15 | 460.24 | 578.11 | 418.99 | 325.13 |
Impairment of Goodwill | - | -44.85 | - | - | -60.51 |
Gain (Loss) on Sale of Investments | 2.81 | -13.22 | -1.07 | -37.83 | 14.15 |
Gain (Loss) on Sale of Assets | 2.46 | 0.09 | 0.04 | -0.87 | -0.46 |
Asset Writedown | -41.01 | -1.52 | -0.36 | -0.11 | -0.11 |
Other Unusual Items | - | 0.52 | 8.63 | 8.29 | 9.91 |
Pretax Income | 236.41 | 401.26 | 585.36 | 388.47 | 288.1 |
Income Tax Expense | 50.66 | 56.25 | 99.57 | 107.04 | 93.27 |
Earnings From Continuing Operations | 185.75 | 345.01 | 485.79 | 281.43 | 194.82 |
Minority Interest in Earnings | 4.34 | 4.67 | 7.24 | 10.03 | 12.22 |
Net Income | 190.09 | 349.68 | 493.03 | 291.46 | 207.05 |
Net Income to Common | 190.09 | 349.68 | 493.03 | 291.46 | 207.05 |
Net Income Growth | -45.64% | -29.07% | 69.16% | 40.77% | 364.49% |
Shares Outstanding (Basic) | 487 | 479 | 470 | 497 | 485 |
Shares Outstanding (Diluted) | 487 | 486 | 483 | 514 | 501 |
Shares Change (YoY) | 0.36% | 0.48% | -6.02% | 2.67% | 4.86% |
EPS (Basic) | 0.39 | 0.73 | 1.05 | 0.59 | 0.43 |
EPS (Diluted) | 0.39 | 0.72 | 1.02 | 0.57 | 0.41 |
EPS Growth | -45.83% | -29.41% | 79.99% | 37.12% | 342.98% |
Free Cash Flow | 117.69 | -18.65 | 110.37 | -14.23 | -184.88 |
Free Cash Flow Per Share | 0.24 | -0.04 | 0.23 | -0.03 | -0.37 |
Dividend Per Share | - | 0.249 | 0.667 | 0.333 | 0.333 |
Dividend Growth | - | -62.61% | 100.03% | - | 2406.01% |
Gross Margin | 45.76% | 46.69% | 56.48% | 46.48% | 39.93% |
Operating Margin | 25.24% | 26.94% | 36.08% | 25.67% | 11.08% |
Profit Margin | 16.13% | 21.77% | 31.14% | 19.62% | 16.97% |
Free Cash Flow Margin | 9.99% | -1.16% | 6.97% | -0.96% | -15.15% |
EBITDA | 407.7 | 526.73 | 645.57 | 443.36 | 207.05 |
EBITDA Margin | 34.61% | 32.79% | 40.77% | 29.84% | 16.97% |
D&A For EBITDA | 110.39 | 93.96 | 74.22 | 61.94 | 71.88 |
EBIT | 297.31 | 432.78 | 571.35 | 381.42 | 135.17 |
EBIT Margin | 25.24% | 26.94% | 36.08% | 25.67% | 11.08% |
Effective Tax Rate | 21.43% | 14.02% | 17.01% | 27.55% | 32.38% |
Revenue as Reported | - | 1,606 | 1,583 | 1,486 | 1,220 |
Advertising Expenses | - | 1.09 | 0.61 | 0.58 | 3.81 |
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.